UNIGENE LABORATORIES INC (UGNE) [Rocket]

In millions, except per share items	Dec-31-12	Dec-31-11	Dec-31-10	Dec-31-09	Dec-31-08	Dec-31-07	Dec-31-06	Dec-31-05
	10-K	10-K	10-K/A	10-K	10-K	10-K	10-K	10-K
Current Assets:
Cash and cash equivalents	3.8	4.7	12.2
Accounts receivable	0.1	2.9	1.6
Inventory, net	2.9	1.3	1.4
Prepaid expenses and other current assets	0.8	0.9	0.7
Total Current Assets	13.2	10.3	16.1
Noncurrent inventory, net	1.1	1.9
Property, plant and equipment, net	2.7	3.0	3.2
Patents and other intangibles, net	1.9	2.0	2.7
Other assets	0.0	0.3	0.3
Total Assets	11.3	18.2	29.2

LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current Liabilities:
Accounts payable	0.7	1.5	1.0
Accrued expenses	2.2	2.1
Accrued interest		11.8	9.3

Current portion – deferred licensing revenues
Current portion – deferred gain on sale/leaseback	0.6	0.7
Current portion – capital lease obligations	0.0
Embedded conversion feature liability	28.7	12.5	22.9

Notes payable – Levys
Total Current Liabilities	104.5	5.7	7.3
Capital lease obligations, excluding current portion	0.0
Deferred licensing revenues, excluding current portion	5.1	6.1	11.2
Deferred gain on sale/leaseback, excluding current portion	0.6	0.7
Total Liabilities	110.1	83.9	91.0

Commitments and Contingencies
Stockholders’ Deficit:
Common Stock – par value $.01 per share	1.0	1.0	0.9
Additional paid-in capital	116.9	115.7	112.5
Accumulated deficit	-216.6	-182.3	-175.2
Total Stockholders’ Deficit	-98.7	-65.7	-61.8
Total Liabilities and Stockholders’ Deficit	11.3	18.2	29.2